The role of azurocidin in patients with familial Mediterranean fever and AA amyloidosis and its association with cardiovascular risk factors.

Published in: International urology and nephrology (2020)

Based on our findings, azurocidin seems to be a good inflammation marker in patients with FMF. Increase in azurocidin levels might be associated with development of amyloidosis. Also, serum azurocidin levels may be used as a predictor of both inflammatory state and cardiovascular risk, especially when used with other markers such as CA-IMT.

Keyphrases

cardiovascular risk factors
oxidative stress
cardiovascular disease
metabolic syndrome
multiple myeloma
early onset
type diabetes